Literature DB >> 32601109

Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Pietro Mastroeni1, Omar Rossi2.   

Abstract

Salmonella causes grave systemic infections in humans and other animals and provides a paradigm for other diseases in which the bacteria have both intracellular and extracellular lifestyles. New generations of vaccines rely on the essential contribution of the antibody responses for their protection. The quality, antigen specificity, and functions associated with antibody responses to this pathogen have been elusive for a long time. Recent approaches that combine studies in humans and genetically manipulated experimental models and that exploit awareness of the location and within-host life cycle of the pathogen are shedding light on how humoral immunity to Salmonella operates. However, this area of research remains full of controversy and discrepancies. The overall scenario indicates that antibodies are essential for resistance against systemic Salmonella infections and can express the highest protective function when operating in conjunction with cell-mediated immunity. Antigen specificity, isotype profile, Fc-gamma receptor usage, and complement activation are all intertwined factors that still arcanely influence antibody-mediated protection to Salmonella.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Antibodies; IgA; IgG; IgM; Salmonellazzm321990; systemic infections; vaccines

Mesh:

Substances:

Year:  2020        PMID: 32601109      PMCID: PMC7504966          DOI: 10.1128/IAI.00219-20

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  143 in total

1.  Cutting edge: B cells are essential for protective immunity against Salmonella independent of antibody secretion.

Authors:  Minelva R Nanton; Sing Sing Way; Mark J Shlomchik; Stephen J McSorley
Journal:  J Immunol       Date:  2012-11-12       Impact factor: 5.422

2.  The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children.

Authors:  Calman A MacLennan; Esther N Gondwe; Chisomo L Msefula; Robert A Kingsley; Nicholas R Thomson; Sarah A White; Margaret Goodall; Derek J Pickard; Stephen M Graham; Gordon Dougan; C Anthony Hart; Malcolm E Molyneux; Mark T Drayson
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

3.  Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing.

Authors:  Melita A Gordon; Stephen B Gordon; Lisa Musaya; Eduard E Zijlstra; Malcolm E Molyneux; Robert C Read
Journal:  AIDS       Date:  2007-11-30       Impact factor: 4.177

4.  Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi.

Authors:  Melita A Gordon; Stephen M Graham; Amanda L Walsh; Lorna Wilson; Amos Phiri; Elizabeth Molyneux; Eduard E Zijlstra; Robert S Heyderman; C Anthony Hart; Malcolm E Molyneux
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

5.  Expression of the innate resistance gene Ity in mouse Kupffer cells infected with Salmonella typhimurium in vitro.

Authors:  K A Harrington; C E Hormaeche
Journal:  Microb Pathog       Date:  1986-06       Impact factor: 3.738

6.  The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response.

Authors:  Cristina Gil-Cruz; Saeeda Bobat; Jennifer L Marshall; Robert A Kingsley; Ewan A Ross; Ian R Henderson; Denisse L Leyton; Ruth E Coughlan; Mahmood Khan; Karina T Jensen; Christopher D Buckley; Gordon Dougan; Ian C M MacLennan; Constantino López-Macías; Adam F Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

Review 7.  Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans.

Authors:  Marcelo B Sztein
Journal:  Clin Infect Dis       Date:  2007-07-15       Impact factor: 9.079

8.  Isotype of protective anti-Salmonella antibodies in experimental mouse salmonellosis.

Authors:  H Saxén; O Mäkelä; S B Svenson
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

9.  Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa.

Authors:  Robert F Breiman; Leonard Cosmas; Henry Njuguna; Allan Audi; Beatrice Olack; John B Ochieng; Newton Wamola; Godfrey M Bigogo; George Awiti; Collins W Tabu; Heather Burke; John Williamson; Joseph O Oundo; Eric D Mintz; Daniel R Feikin
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

Review 10.  Vaccines against invasive Salmonella disease: current status and future directions.

Authors:  Calman A MacLennan; Laura B Martin; Francesca Micoli
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

View more
  3 in total

1.  Aryl Hydrocarbon Receptor Activation by Benzo[a]pyrene Prevents Development of Septic Shock and Fatal Outcome in a Mouse Model of Systemic Salmonella enterica Infection.

Authors:  Christiane Fueldner; Sina Riemschneider; Janine Haupt; Harald Jungnickel; Felix Schulze; Katharina Zoldan; Charlotte Esser; Sunna Hauschildt; Jens Knauer; Andreas Luch; Stefan Kalkhof; Jörg Lehmann
Journal:  Cells       Date:  2022-02-20       Impact factor: 6.600

Review 2.  Paratyphoid Fever A: Infection and Prevention.

Authors:  Lei Xie; Lan Ming; Manlin Ding; Luxin Deng; Miao Liu; Yanguang Cong
Journal:  Front Microbiol       Date:  2022-07-08       Impact factor: 6.064

Review 3.  Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases.

Authors:  Joaquin Miguel Pellegrini; Jean-Pierre Gorvel; Sylvie Mémet
Journal:  Microorganisms       Date:  2022-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.